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An accompanying paper from this Centrec
reports deterioration of cycloserine in humid tro-
pical climates and recommends various preventive
measures. However, in spite of all precautions, it
would be advisable for those using cycloserine
in humid climates to ensure periodically that
there. is no loss of drug content. Quantitative
assay procedures (for example, that described by
Jones d), although very desirable, are cumbersome
and cannot be undertaken in institutions with
limited laboratory facilities. A simple qualitative
test that can be used under these circumstances
is described below. The test is based on the obser-
vation that samples of deteriorated cycloserine
form yellow solutions when dissolved in dilute
alkali.
Materials and methods
The stated content of the tablets and capsules
of cycloserine used in the present investigation
was 250 mg; our findings, however, indicate that
the content was frequently about 5% higher. It
is stated in the British Pharmacopoeia e, f that,
taking into account tolerances for manufacturing
variations, 92.5%–107.5% of the stated content
are acceptable limits for tablets, and 90.0%–
110.0% are acceptable limits for capsules (B.P.
limits).
The qualitative test has been designed to detect
deterioration if the cycloserine content of tablets
or capsules falls below 225 mg, that is, below
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90% of the stated content of 250 mg. In view
of the excess content of approximately 5%, this
implies that the test is designed to detect deterio-
ration of about 15 % or more.
Qualitative test. Each tablet was ground up with
5 ml of 0.4 N sodium hydroxide solution in a
glass mortar and the resulting suspension was
transferred to a test-tube. The contents of each
capsule were directly added to the alkali in a test-
tube and mixed well.
The presence of a yellow colour in the suspen-
sion within 5 minutes was regarded as a “ posi-
tive ” finding. Suspensions which were light yellow
or white were classified as “negative.” (To facilitate
standardization in reading the colour reaction, a
suspension of 150 mg of calcium carbonate in 5 ml
of 0.01 % potassium dichromate solution may be
employed as a standard positive.)
Qua titative assay. After the completion of the
qualitative test, the cycloserine content of the
solution in the test-tube plus any residual material
on the mortar or pestle or both was determined
by the method of Jones,d using pure cycloserine as
a s a dard. Pure cycloserine was supplied by the
manufacturers in powder form in heat-sealed,
amber-coloured ampoules, and stored at the Cen-
tre in a cold-room at a temperature of approxi-
mately 9°C.
R sults of Investigation 1
A preliminary investigation was undertaken to
compare the findings of the qualitative test with
2 different concentrations of sodium hydroxide
solution (0.4 N and 0.5 N). For this purpose, a
total of 57 tablets and 38 capsules were taken
from stocks that were known to be fully potent
(that is, each contained at least 250 mg cyclose-
rine), and from stocks that were known to have
deteriorated. The findings are presented in Table 1.
It can be seen that a positive reaction with 0.4 N
alkali indicates always that the cycloserine content,
whether of tablets or capsules, is less than 90%
of the stated content. In contrast, with 0.5 N
alkali, a positive reaction was obtained even when
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TABLE 1
R E S U L T S  O F  Q U A L I T A T I V E  T E S T S  W I T H  0 . 4  N  A N D  0 . 5  N  S O D I U M  H Y D R O X I D E ,
RELATED TO CYCLOSERINE CONTENT
Sodium
hydroxide
concentration
Positive result Negative result
Form of
cycloserine No. of
specimens
Range of No. of
Range of
cycloserine
  content (%) a      s p e c i m e n s
cycloserine
content (%) a
22
0.4 N
9
70-86 9 91-106
62-86 14 87-106
65-96 15 98-104
91-99 8 99-106
a Expressed as a percentage of the stated content of 250 mg.
the cycloserine content was as high as 96%
for tablets and 99% for capsules. As the aim of
the test is to detect a fall in content to less than
90% of the stated amount, the findings with 0.4 N
alkali are clearly more satisfactory. Consequently,
0.4 N alkali alone was used in the second inves-
tigation.
Results of Investigation 2
Since cycloserine is normally dispensed in tablet
form at this Centre, the relationship between the
results of the qualitative and quantitative tests was
studied in a further batch of 62 tablets, 10 of
which were known to be fully potent while the
remainder was from batches known to contain at
least 70% of the stated cycloserine content. The
tablets were sent under code numbers to the
biochemist, who examined them by the qualitative
test ; next, the test-tubes containing the cycloserine
solutions were given new code numbers and
quantitative assays were undertaken. The findings
are presented in Table 2.
Of the 26 tablets which yielded a positive result,
23 (88%) had a cycloserine content of less than
90%, while the remaining 3 had a content of
91% each. In contrast, only 6 (17%) of the
36 tablets showing a negative result hod a content of
less than 90%, the lowest value being 83 % ; of the
remaining 30, 21 had a content of at least 93 %.
In summary, these investigations have shown
that a positive result in the qualitative test always
indicates that the drug content is less than the
minimum B.P. limit, and a negative result indi-
 cates that the drug content is 80% or more of the
stated content.
Agreement between duplicate observers in reading
the test reaction
Of the 62 tests in Investigation 2, 41 were read
independently by a second reader, who had no
previous experience with the test. Both readers
classified 10 reactions as positive (80%-91 % of
stated content of cycloserine) and 30 as negative
(83%-106 % of the stated content). One test reac-
tion was classified as negative by the experienced
reader and as positive by the other; the cyclose-
rine content of this tablet was 91%.
Comments
We have observed that deteriorated tablets and
capsules of cycloserine, when dissolved in dilute
T A B L E 2
R E S U L T S  O F  Q U A L I T A T I V E  A N D  Q U A N T I T A T I V E  T E S T S
ON CYCLOSERINE TABLETS
Cycloserine
content (%) a
< 8 0
80-84
85-89
90-92
93-94
> 9 5
Qualitative test result b
Positive  N e g a t i v e
4 0
10 1
9 5
3 9
0
0
Total number of tablets
                  3 6
26
Range of cycloserine content (%)a 70-91 83-106
a Expressed as a percentage of the stated content of 250 mg.
b Using 0.4 N sodium hydroxide solution.
NOTES 844
alkali, yield yellow solutions which strongly absorb
ultraviolet light in the 280 nm–290 nm band
and give a positive biuret reaction. This indicates
that the deteriorated product is of a diketopi-
perazine nature, an observation which is in agree-
ment with that of Hidy et al.g th t cycloserine
dimerizes in solution into 2,5-bis-(aminoxymethyl)
3,6-diketopiperazine.
The biuret reaction is very sensitive, that is, the
result is positive even if the extent of deterioration
is very small. It is therefore not suitable, parti-
cularly since the cycloserine content of tablets or
capsules is frequently about 5% more than that
stated, for screening batches of cycloserine as satis-
   factory or unsatisfactory, employing B.P. limits.
g Hidy, P. H. et al. (1955) J. Amer. chem. Soc., 77, 2345.
It has been demonstrated that, if the initial
cycloserine content is about 5% in excess of the
stated amount, a positive result with the qualita-
tive test always indicates that the cycloserine con-
tent is less than the minimum B.P. limit. In prac-
tice, therefore, a useful working rule would be to
r ject all batches with a positive result as unsatis-
factory. Although such a rule will usually ensure
that only unsatisfactory batches are rejected, it
cannot ensure that all batches which are accepted
as satisfactory are, in fact, above the minimum
B.P. limit. For instance, in the present study,
1 of 11 tablets with a content of 80%–84%, 5 of 14
with a content of 85%–89% and 9 of 12 with
a content of 90%–92% of the stated content
yielded a negative result, although the content was
less than the minimum B.P. limit.
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